MS vs NRXS · P/E 20, rev $41.93B vs rev $3.6M
Morgan Stanley (MS) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported MS revenue for 2026-06-30 was $41.93B. Net income was $11.15B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the MS and NRXS stock pages for the full models.
Not investment advice.